COVID-19


CellR4 2022; 10: e3322
DOI: 10.32113/cellr4_20228_3322

The cellular markers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immune response

CellR4 2021; 9: e3058
DOI: 10.32113/cellr4_20212_3058

The role of Th17 cells in SARS-CoV-2 infection: implementation for the therapy of severe COVID-19 cases

CellR4 2020; 8: e2955
DOI: 10.32113/cellr4_202010_2955

Human islet distribution during COVID-19 pandemic: the impact on diabetes research

CellR4 2020; 8: e2957
DOI: 10.32113/cellr4_202010_2957

Islet cell transplantation: the effects of COVID-19 pandemic

CellR4 2020; 8: e2846
DOI: 10.32113/cellr4_20205_2846

Editorial – Potential risks of the SARS-related coronavirus 2 infection [COVID-19] in pregnancy

CellR4 2020; 8: e2852
DOI: 10.32113/cellr4_20205_2852

Challenges in managing immunosuppressive therapies for psoriasis during the COVID-19 pandemic

CellR4 2020; 8: e2854
DOI: 10.32113/cellr4_20205_2854

The impact of COVID-19 pandemic on pediatric oncology

CellR4 2020; 8: e2839
DOI: 10.32113/cellr4_20204_2839

Umbilical cord-derived mesenchymal stem cells for COVID-19 patients with acute respiratory distress syndrome (ARDS)